iFrame.AI – Discover What Matters

ALL MEDICAL CODES IN CATEGORY J9000-J9999 (Chemotherapy Drugs)

2025 HCPCS code J9281

Mitomycin pyelocalyceal instillation, 1 mg. This code represents one milligram of mitomycin, an anticancer antibiotic, administered into the renal pelvis.

2025 HCPCS code J9359

Injection, loncastuximab tesirine-lpyl, 0.075 mg

2025 HCPCS code J9370

Vincristine sulfate, 1 mg, administered intravenously.

2025 HCPCS code J9390

Injection, vinorelbine tartrate, 10 mg

2025 HCPCS code J9213

Injection, interferon, alfa-2a, recombinant, 3 million units

2025 HCPCS code J9058

Injection, bendamustine hydrochloride (Apotex), 1 mg

2025 HCPCS code J9033

Injection, bendamustine HCl (Treanda), 1 mg

2025 HCPCS code J9056

Injection, bendamustine hydrochloride (Vivimusta), 1 mg

2025 HCPCS code J9214

Injection, interferon alfa-2b, recombinant, 1 million units.

2025 HCPCS code J9280

Mitomycin injection, 5 mg

2025 HCPCS code J9268

Injection, pentostatin, 10 mg. This code represents the drug pentostatin for intravenous injection, with one unit equaling 10 mg.

2025 HCPCS code J9071

Injection, cyclophosphamide (AuroMedics), 5 mg.

2025 HCPCS code J9316

Injection, pertuzumab, trastuzumab, and hyaluronidase-zzxf, per 10 mg.

2025 HCPCS code J9322

Injection, pemetrexed (BluePoint), not therapeutically equivalent to J9305, 10 mg.

2025 HCPCS code J9286

Injection, glofitamab-gxbm, 2.5 mg

2025 HCPCS code J9311

Injection, rituximab, 10 mg

2025 HCPCS code J9353

Injection, margetuximab-cmkb, 5 mg; a monoclonal antibody used in intravenous infusion to treat breast cancer.

2025 HCPCS code J9021

This HCPCS code represents 0.1 mg of recombinant asparaginase (Rylaze), administered via intramuscular injection to treat leukemia and lymphoma.

2025 HCPCS code J9229

This HCPCS code represents the supply of 0.1 mg of inotuzumab ozogamicin, an intravenous injection used to treat relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL) in adults.

2025 HCPCS code J9119

This HCPCS code represents 1 mg of cemiplimab-rwlc administered intravenously to treat locally advanced or metastatic cutaneous squamous cell carcinoma.

2025 HCPCS code J9340

This HCPCS code represents the supply of 15 mg of thiotepa for intravenous administration.

2025 HCPCS code J9181

HCPCS code J9181 represents 10 mg of etoposide for injection.

2025 HCPCS code J9175

J9175 represents 1 mL of Elliotts' B solution, a sterile isotonic diluent used for intrathecal drug administration.

2025 HCPCS code J9273

This HCPCS code represents 1 mg of tisotumab vedotin-tftv, a chemotherapy drug administered intravenously to treat cervical cancer.

2025 HCPCS code J9039

Injection, blinatumomab, 1 microgram;one unit represents 1 mcg of blinatumomab.

2025 HCPCS code J9360

Vinblastine sulfate, an antineoplastic agent, is used to treat various cancers. This code represents 1 mg of vinblastine sulfate administered intravenously.

2025 HCPCS code J9295

Injection, necitumumab, 1 mg

2025 HCPCS code J9015

Injection, aldesleukin, per single use vial.

2025 HCPCS code J9394

Injection, fulvestrant (Fresenius Kabi), not therapeutically equivalent to J9395, 25 mg.

2025 HCPCS code J9212

This HCPCS code represents the supply of 1 microgram of recombinant interferon alfacon-1 for subcutaneous injection.

2025 HCPCS code J9330

Injection, temsirolimus, 1 mg; this HCPCS code represents the supply of the drug, not its administration.

2025 HCPCS code J9060

Cisplatin injection, 10mg.

2025 HCPCS code J9178

Injection, epirubicin HCl, 2 mg; this code represents the supply of the drug, not its administration.

2025 HCPCS code J9262

Omacetaxine mepesuccinate injection, 0.01 mg.

2025 HCPCS code J9314

This HCPCS code represents 10 mg of pemetrexed (Teva), a chemotherapy drug used to treat non-squamous non-small cell lung cancer.

2025 HCPCS code J9176

Injection, elotuzumab, 1 mg; represents the drug supply only, not administration.

2025 HCPCS code J9153

Injection, liposomal, daunorubicin and cytarabine, 1 mg

2025 HCPCS code J9151

Injection, daunorubicin citrate, liposomal formulation, 10 mg

2025 HCPCS code J9200

Injection, floxuridine, 500 mg

2025 HCPCS code J9145

Injection, daratumumab, 10 mg

2025 HCPCS code J9041

Injection, bortezomib, 0.1 mg

2025 HCPCS code J9029

Nadofaragene firadenovec-vncg, intravesical instillation, per therapeutic dose

2025 HCPCS code J9000

Injection, doxorubicin hydrochloride, 10 mg

2025 HCPCS code J9046

Injection, bortezomib, (Dr. Reddy's), not therapeutically equivalent to J9041, 0.1 mg

2025 HCPCS code J9331

Injection, sirolimus protein-bound particles, 1 mg.

2025 HCPCS code J9272

Injection, dostarlimab-gxly, 10 mg; a monoclonal antibody used in the treatment of endometrial cancer and certain solid tumors.

2025 HCPCS code J9226

Histrelin implant (Supprelin LA), 50 mg; represents the drug only, not the implantation procedure.

2025 HCPCS code J9049

Injection, bortezomib (Hospira), 0.1 mg; not therapeutically equivalent to J9041.

2025 HCPCS code J9177

J9177 represents a 0.25 mg injection of enfortumab vedotin-ejfv, a cytotoxic drug used intravenously to treat specific urothelial cancers.

2025 HCPCS code J9052

This HCPCS code represents 100 mg of carmustine (Accord), a chemotherapy drug administered intravenously.

Enterprise Edition

Upgrade for detailed insurance, legislation, and other documents analytics for individual cases; real-time analysis of the datasets from your EHR, CRM, ERP, or other software; and more Enterprise Features.